GKB Ophthalmics Ltd. - Research Center
533212 GKB Group (XT) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
| 12.63 |
18.95 |
22.48 |
25.36 |
27.73 |
Secured loans
| 18.09 |
11.08 |
11.22 |
11.75 |
11.32 |
Unsecured loans
Total
| 35.76 |
35.07 |
38.73 |
42.16 |
44.09 |
Gross block
| 43.23 |
42.46 |
41.39 |
42.98 |
42.17 |
Less : revaluation reserve
Less : accumulated depreciation
| 28.79 |
26.57 |
24.11 |
21.71 |
19.88 |
Net block
| 14.44 |
15.89 |
17.28 |
21.27 |
22.28 |
Capital work-in-progress
Investments
| 11.90 |
11.90 |
11.90 |
11.90 |
12.22 |
Current assets, loans & advances
| 19.36 |
16.82 |
16.15 |
17.44 |
21.14 |
Less : current liabilities & provisions
| 13.73 |
13.33 |
10.42 |
11.73 |
12.78 |
Total net current assets
Miscellaneous expenses not written
Total
| 35.76 |
35.07 |
38.73 |
42.16 |
44.09 |
Book value of unquoted investments
| 11.90 |
11.90 |
11.90 |
11.90 |
11.90 |
Market value of quoted investments
Contingent liabilities
| 18.43 |
20.05 |
19.37 |
21.96 |
21.59 |
Number of equity sharesoutstanding (Lacs)
| 50.41 |
50.41 |
50.41 |
50.41 |
50.41 |